The role of dipeptidylpeptidase-4 inhibitors in management of cardiovascular disease in diabetes; focus on linagliptin

Multiple population based analyses have demonstrated a high incidence of cardiovascular disease (CVD) and cardiovascular (CV) mortality in subjects with T2DM that reduces life expectancy by as much as 15 years...

Source: Cardiovascular Diabetology - April 18, 2018 Category: Cardiology Authors: Annayya R. Aroor, Camila Manrique-Acevedo and Vincent G. DeMarco Tags: Review Source Type: research